Last reviewed · How we verify
NCT04928872
Macronutrient Distribution and Plasma Metabolites to Model Meals Composition
trial testing Predefined meal in Glucose Metabolism in 23 participants. Completed in 14 January 2020.
14 January 2020
Quick facts
| Lead sponsor | Texas A&M University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 20 June 2018 |
| Primary completion | 14 January 2020 |
| Estimated completion | 14 January 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Predefined meal
Conditions studied
- Glucose Metabolism — all drugs for Glucose Metabolism →
Sponsor
Texas A&M University
Who can join
Adults 60 to 85, any sex, with Glucose Metabolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI) CHO with low GI CHO. However, the protein and fat content of the meal can have a significant impact on the glucose readings obtained from a CGM as there is no enough data available on their sensitivity during meals.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes.
Cruthirds CL, Deutz NEP, Mizubuti YGG, Harrykissoon RI, et al · · 2022 · cited 11× · PMID 36457012 · DOI 10.1186/s12986-022-00714-z -
Discordance between postprandial plasma glucose measurement and continuous glucose monitoring.
Barua S, A Wierzchowska-McNew R, Deutz NEP, Sabharwal A. · · 2022 · cited 7× · PMID 35776949 · DOI 10.1093/ajcn/nqac181 -
Estimating Breakfast Characteristics Using Continuous Glucose Monitoring and Machine Learning in Adults With or at Risk of Type 2 Diabetes.
Pai R, Barua S, Kim BS, McDonald M, et al · · 2026 · cited 5× · PMID 39311452 · DOI 10.1177/19322968241274800 -
Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.
Hüttl VN, Deutz N, Wierzchowska-McNew RA, Ruebush LE, et al · · 2026 · PMID 42149813 · DOI 10.1093/ajh/hpag047
Verify or expand the search:
- PubMed search for NCT04928872
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glucose Metabolism
Currently open trials in the same condition.
- NCT07020741 — Stable Isotopes- Adults With Obesity · NA · recruiting
- NCT06700525 — StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time · NA · recruiting
- NCT05216042 — GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study · NA · recruiting
Other Texas A&M University trials
Trials by the same sponsor.
- NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
- NCT06950775 — The Neighborhood & Health Study · recruiting
- NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
- NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
- NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04928872 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
- Last refreshed: 21 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04928872.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing